Bronchoalvolar Lavage (BAL) in diffuse lung disease: Pros & Cons

C. Robalo Cordeiro (Coimbra, Portugal)

Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Number: 7
Disease area: Interstitial lung diseases

Slide presentationPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Robalo Cordeiro (Coimbra, Portugal). Bronchoalvolar Lavage (BAL) in diffuse lung disease: Pros & Cons. Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Titel: MicroRNA analysis in Epithelial Lining Fluid (ELF) compared to Bronchoalveolar Lavage (BAL) in Interstitial pulmonary fibrosis (IPF)
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Transbronchial lung cryobiopsy (TBLC) and bronchoalveolar lavage (BAL) in diagnosis of Intersticial Lung Diseases (ILD)
Source: International Congress 2019 – Interventional pulmonology techniques: targeting selective lung tissue
Year: 2019


The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014

Interleukin 27 (IL27) as antitumor tool? Results from bronchoalveolar lavage (BAL) examination
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Flow cytometry (FC) in examination of broncholaveolar lavage (BAL) in interstitial lung diseases (ILD). Presentation of 14 years‘ experience
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016


Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018


Expression phenotypes of CD4+ and CD8+ T lymphocytes in bronchoalveolar lavage fluid and blood in lung fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014

Cytokine expression profiles of lymphocytes from bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases(ILDs)
Source: International Congress 2014 – ILDs 5
Year: 2014

Comparison between Bronchoalveolar Lavage (BAL) and blood-derived microvesicles in lung diseases
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



Workstation 2: How to process bronchoalveolar lavage (BAL)
Source: International Congress 2015 – EW6 Research bronchoscopies
Year: 2015

Workstation 2: How to process bronchoalveolar lavage (BAL)
Source: International Congress 2015 – EW2 Research bronchoscopies
Year: 2015

Workstation 2: How to process bronchoalveolar lavage (BAL)
Source: International Congress 2015 – EW4 Research bronchoscopies
Year: 2015

Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013